Ascentage Pharma Group International AAPG
NASDAQ AAPG
$15.90 -0.59 (-3.63%)
As of: Oct 1, 2026 · 2:20 PM EDT

Ascentage Pharma Group International (AAPG) Long-Term Deferred Tax (2022 - 2026)

Updated

Ascentage Pharma Group International (AAPG) recorded Long-Term Deferred Tax of $2.71 million in Q2 2026, down 41.9% from $4.66 million a year earlier.

Analysis

Ascentage Pharma Group International (AAPG) Long-Term Deferred Tax (2022 - 2026) Analysis & Trends

At the end of FY2025, Ascentage Pharma Group International reported Long-Term Deferred Tax of $4.57 million, down 24.6% from FY2024.

  • Annual Long-Term Deferred Tax has declined for three straight years, with a three-year compound annual growth rate of -19.9% (FY2022 to FY2025).
  • Across earlier years, Long-Term Deferred Tax came in at $6.06 million in FY2024 (-28.4%), $8.47 million in FY2023 (-4.6%) and $8.88 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Ascentage Pharma Group International 1.55 Bn 517.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.71 Mn
Dec 31, 2025 4.51 Mn
Jun 30, 2025 4.66 Mn
Dec 31, 2024 6.16 Mn
Dec 31, 2023 8.31 Mn
Dec 31, 2022 8.38 Mn
API Access

Ascentage Pharma Group International Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=AAPG&period=max&api_key=YOUR_API_KEY